ERIS Lifesciences Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Financial Year | Sep '26 | ||||
|---|---|---|---|---|---|
Total Qtr Revenue cr | 895.57 | ||||
| Other Income Qtr Cr | 3.20 | ||||
| Operating Revenues Qtr | 892.37 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 583.02 | ||||
Operating Profit Qtr | 309.35 | ||||
EBITDA Qtr Cr | 276.65 | ||||
Depreciation Qtr | 73.42 | ||||
Net Profit Qtr | 183.82 | ||||
Basic EPS Qtr | 13.26 | ||||